Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    The Value of axitinib in combination with Immuno-oncology (IO) in Patients with Metastatic Renal Cell Carcinoma (mRCC)
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology China
    Innovative Digital Health Projects to increase the Quality of Life (QoL) of Multiple Myeloma (MM) patients
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement Oncology Italy
    2024 RD Global Monitoring anti-TFPI RES
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Call for Independent Medical Education Grant Applications Oncology – Urothelial Carcinoma (UC)
    Release Date:
    Partner: Astellas
    Review Process: Pfizer Internal
    Education Oncology All
    Health Services Research to Improve Management of mBC Patients Treated with Tucatinib
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology All
    Addressing Multiple Myeloma Gaps in Care for Patients in Latin America
    Release Date:
    Partner: International Myeloma Foundation
    Review Process: Expert Review Panel
    Education Oncology Argentina, Brazil, Colombia, Mexico
    Providing Appropriate Medical Care for IBD Patients
    Release Date:
    Partner: Japanese Society for Inflammatory Bowel Disease (JSIBD)
    Review Process: Expert Review Panel
    Translation: Japanese (link)
    Quality Improvement Inflammation & Immunology Japan
    Management of Atopic Dermatitis / Alopecia Areata
    Release Date:
    Review Process: Pfizer Internal
    Education Inflammation & Immunology USA
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Education for Improving Appropriate Diagnosis and Treatment for Venous Thromboembolism
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Education and Support for Patients with Locally-Advanced or Metastatic Bladder Cancer
    Release Date:
    Partner: Merck KGaA, Darmstadt, Germany and EMD Serono
    Review Process: Pfizer Internal
    Education Oncology USA
    Pre-clinical & Translational Research in Multiple Myeloma
    Release Date:
    Review Process: Pfizer Internal
    Research Oncology Canada, USA
    Management of Patients with BRAF-mutant metastatic colorectal cancer
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Canada, USA
    Promotion of Smoking Cessation Treatment in General Practice
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine Japan
    Quality Improvement Grants to Support the Delivery of Gene Therapies to Patients with Rare Disease
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Rare Disease All
    2021 Growth Hormone Research (All countries except for the United States)
    Release Date:
    Review Process: Pfizer Internal
    Research Rare Disease All
    Closing Knowledge Gaps in Osteoarthritis and Osteoarthritis Pain
    Release Date:
    Partner: Lilly
    Review Process: Pfizer Internal
    Education Internal Medicine All
    NSCLC Therapy Management for Optimal Outcomes
    Release Date:
    Review Process: Pfizer Internal
    Quality Improvement Oncology Andorra, Austria, Belgium, Canada, Denmark, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Malta, Monaco, Netherlands, Norway, Portugal, San Marino, Spain, Sweden, Switzerland, USA, United Kingdom
    Clinical Research Capability Development
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine China
    Educational Program to Increase Awareness and Treatment of Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease China
    Improve the care of patients living with metastatic breast cancer
    Release Date:
    Partner: Rethink Breast Cancer
    Review Process: Expert Review Panel
    Quality Improvement Oncology Canada